Brostallicin
Names | |
---|---|
IUPAC name
4-[(2-Bromoacryloyl)amino]-N-{5-[(5-{[5-({2-[(diaminomethylene)amino]ethyl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]carbamoyl}-1-methyl-1H-pyrrol-3-yl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}-1-methyl-1H-pyrrole-2-carboxamide | |
Identifiers | |
ChemSpider | 5293605 |
| |
Jmol-3D images | Image |
PubChem | 6918408 |
| |
Properties | |
Molecular formula |
C30H35BrN12O5 |
Molar mass | 723.58 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Brostallicin is a chemical compound being studied in the treatment of cancer. It is an alkylating agent that binds DNA.[1]
References
- ↑ Brostallicin entry in the NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".